M-m-r II vaccine vials
Ended Awarded Last action
- Contract number
- SPE2DR26F65W4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,178
Award facts
- Contract value 100% obligated
- $3,177.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,177.90 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 15, 2026, with completion scheduled for January 16, 2026. This is a firm fixed-price contract with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing critical medical commodities to federal agencies, particularly the Department of Defense and Defense Health Agency. The M-M-R II vaccine order falls within the contractor's established portfolio of vaccine and medical supply deliveries under the comprehensive IDC vehicle. As a single-award IDC holder, Cencora leverages its global pharmaceutical supply network to support military treatment facilities and veteran healthcare programs with specialty medications, generic drugs, vaccines, syringes, vials, and related medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F65W4?
SPE2DR26F65W4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F65W4 worth?
The government has obligated $3,178 on SPE2DR26F65W4.
Is contract SPE2DR26F65W4 an order under another contract?
Yes. SPE2DR26F65W4 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F65W4 competed?
The extent of competition for SPE2DR26F65W4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award